• May 30, 2013
    Finding time in a hectic veterinary practice to order animal health products from Zoetis just became faster and easier, thanks to a new web-based ordering site that offers customers in the United States 24/7 access to more than 300 product lines that support the health of beef and dairy cattle, poultry, pigs, dogs, cats, horses and sheep. The new eCommerce site (www.zoetisus.com click on SHOP)—the industry’s most robust and personalizedmore...
  • May 16, 2013
    MADISON, N.J.--(BUSINESS WIRE)--Zoetis, Inc. (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved APOQUEL® (oclacitinib tablet) for the control of pruritus associated with allergic dermatitis and the control of atopic dermatitis in dogs at least 12 months of age. Pruritus, or itching, is the most common sign of allergies in dogs. Developed by Zoetis, APOQUEL is the first Janus kinase (JAK)more...
  • April 18, 2013
    Zoetis Inc., formerly the animal health business unit of Pfizer Inc., today announced the first recipients of the company’s Excellence in Dermatology™ Research Grant program. The objective of the new program is to support research in the area of basic science diagnosing and treating dermatologic conditions in dogs and cats. Investigators from the University of Pennsylvania and Johns Hopkins University will receive one grant to pursuemore...
  • April 15, 2013
    ZoetisTM, formerly the animal health business unit of Pfizer Inc., today announced the U.S. Department of Agriculture (USDA) has approved a newly-enhanced version of the WITNESS® HW Heartworm Antigen Test kit for dogs and cats. Launched today, the enhanced WITNESS HW test kit is now available to veterinarians nationwide. Enhancements to the biologics, including test antibodies, improvements to the buffer and sample pad and improve themore...
  • November 1, 2012
    Australian horse owners who are battling against the deadly Hendra virus received an important boost today with the introduction of Equivac® HeV vaccine. The Equivac® HeV vaccine will be available for use under permit by accredited veterinarians thanks to an international public-private partnership created to make this important new vaccine accessible. The vaccine, launched by Pfizer Animal Health, will help prevent the spread of the Hendramore...
  • July 25, 2012
    VANCOUVER, British Columbia--Data to be presented this week at the 7th World Congress of Veterinary Dermatology (WCVD) Meeting 2012 will report new insights into the disease pathways involved in allergic conditions in dogs, Pfizer Animal Health announced today. Researchers with Pfizer Animal Health’s Global Therapeutic Research Group have, for the first time, identified a potential role for the cytokine IL-31 in triggering itchmore...
  • July 25, 2012
    VANCOUVER, British Columbia--Pfizer Animal Health will present data from discovery studies validating specific pathways of allergic skin disease in dogs and studies evaluating novel molecules targeting these pathways at the 7th World Congress of Veterinary Dermatology (WCVD) Meeting 2012 in Vancouver, British Columbia, from July 24–28. Approximately six presentations related to Pfizer’s research and development program in veterinary dermatologymore...
  • April 19, 2012
    PARIS, France--The famous Auzoux Horse, one of the first veterinary teaching aids of its kind, has been restored to its former glory thanks to a €50,000 grant from Pfizer Animal Health. The papier-mâché model dates back to 1846 and was initially created to allow veterinary students to mimic a dissection without having to use an actual cadaver, an unpleasant and dangerous choice in an era when it was not uncommon for people to die ofmore...
  • January 27, 2012
    Dozulé, Normandy, France--Pfizer Animal Health and The Hippolia Foundation announced today the formation of a strategic partnership to advance equine health through research and educational programmes. The Hippolia Foundation – a network of leading French equine institutions together with international partners – will collaborate with Pfizer to accelerate advancement in innovation on the diagnosis, treatment and prevention of equinemore...
  • November 8, 2011
    KALAMAZOO, Mich.--Pfizer Animal Health affirmed its commitment to innovation in equine health with the opening today of the Pfizer Animal Health Equine Research Center in Richland, Mich. The center, the culmination of a $7 million investment, expands Pfizer Animal Health’s global research and development network headquarters in Kalamazoo, Mich., and will serve as the worldwide hub for research and development of equine vaccines and novelmore...